Gerresheimer nears Centor sale close as Q2 adjusted EBITDA rebounds over 50%
Gerresheimer said preparations to close the sale of its Centor closures business are in their final stages, with completion expected in October 2026; Centor and the Primary Packaging Plastics unit together carry an enterprise value of about EUR 1.5bn, and the PPP sale is targeted for the first half of 2027. Closure of the Chicago Heights moulded glass plant was due to be completed by the end of September 2026. Preliminary second-quarter revenue was EUR 578m with adjusted EBITDA of EUR 102m, more than 50% above the first quarter.
Why this mattersThe divestments and plant closure accelerate Gerresheimer's shift to a pure pharma and drug-delivery packaging group as it works to rebuild its balance sheet.
- Preparations for closing the Centor sale are in their final stages, with the transaction expected to close in October 2026.
- Centor and Primary Packaging Plastics have a combined enterprise value of about EUR 1.5bn; the PPP sale is targeted to close in the first half of 2027.
- Closure of the Chicago Heights moulded glass plant was targeted for completion by the end of September 2026.
- Q2 2026 adjusted EBITDA was EUR 102m, up EUR 35m or more than 50% from EUR 67m in Q1 2026.
- Q2 2026 revenue was EUR 578m, against EUR 614m in Q2 2025 and EUR 523m in Q1 2026.
- H1 2026 revenue was EUR 1.10bn and adjusted EBITDA EUR 168m, versus EUR 1.14bn and EUR 224m in H1 2025.